Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
BMC
2023-05-01
|
| Saila: | Journal of Translational Medicine |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12967-023-04186-4 |